Table 1.
Clinical Characteristics of 90 Participants.
| Clinical characteristics | Cachexia (n=42) | Noncachexia (n=48) | T/x2 | p Value |
|---|---|---|---|---|
| Age | 65.40±7.53 | 61.77±11.41 | 1.755 | 0.056 |
| BMI | 20.76±1.74 | 24.14±1.92 | 8.692 | 0.049∗ |
| Weight Loss | 6.95±2.98 | 0.91±0.53 | 15.026 | <0.001∗ |
| Disease stage(III/IV) | 36/42 | 16/48 | 7.174 | <0.001∗ |
| IL6(mmol/L) | 9.59±5.58 | 4.32±1.60 | 6.245 | <0.001∗ |
| TNFa(mmol/L) | 13.89±6.36 | 10.10±3.86 | 3.460 | 0.001∗ |
| Alb (g/L) | 38.33±3.93 | 41.81±5.11 | 3.577 | 0.116 |
| PAb(mg/L) | 196.0±61.81 | 252.33±29.84 | 5.613 | <0.001∗ |
| FAA(mmol/L) | 0.57±0.15 | 0.33±0.10 | 8.761 | <0.012∗ |
| TC(mmol/L) | 4.22±1.07 | 4.31±0.81 | 0.925 | 0.275 |
| TG(mmol/L) | 1.10±0.42 | 1.54±0.84 | 3.076 | 0.015∗ |
| LDL(mmol/L) | 2.49±0.97 | 2.46±0.67 | 0.123 | 0.155 |
| HDL(mmol/L) | 1.16±0.36 | 1.17±0.30 | 0.229 | 0.212 |
| ApoA(g/L) | 1.13±0.23 | 1.28±0.21 | 3.144 | 0.218 |
| ApoB(g/L) | 0.79±0.26 | 0.78±0.18 | 0.043 | 0.058 |
| ApoE(mg/L) | 39.50±17.78 | 44.85±10.55 | 1.762 | 0.002∗ |
| HB(g/L) | 125.64±23.28 | 127.77±16.96 | 2.848 | 0.282 |
| WBC(10ˆ9/L) | 6.02±1.83 | 6.15±1.88 | 0.333 | 0.790 |
| PLT(10ˆ9/L) | 224.83±80.65 | 232.68±99.17 | 0.408 | 0.612 |
| circPTK2 | 5.09±3.01 | 1.98±1.26 | 6.525 | 0.001∗ |
BMI Body mass index, HB Hemoglobin, WBC White blood cell count, PLT Platelet, ALB Albumin, PAb Prealbumin, TC Total cholesterol, TG Tri-glyceride, LDL Low-density lipoprotein, HDL High-density lipoprotein, ApoA Apolipoprotein A, ApoB Apolipoprotein B, ApoE Apolipoprotein E, FFA Free fatty acid, IL-6 Interleukin 6, TNF-α Tumor Necrosis Factor-α.